Following the successful development and rapid roll-out of its COVID-19 vaccine, Moderna (Nasdaq: MRNA) has wasted no time in seeking to prove that it is not a 21 July 2023
As the crowds descend on Chicago for the annual meeting of the American Society of Clinical Oncology (ASCO), The Pharma Letter interviews Eisai chief medical of 1 June 2023
The progress quietly made by Sino-American biotech company Beigene (Nasdaq: BGNE) with its oral Bruton tyrosine kinase inhibitor (BTKi) Brukinsa (zanubrutinib) 30 March 2023
Research-based Egyptian pharma company Gennecs Pharmaceuticals, part of the Gennecs group, belongs to the to El Daba Holding Group, a trading conglomerate servi 20 March 2023
Zeta Pharma is a fast-growing branded generic pharmaceutical company in the Egyptian market that was established in 2010 and started its production and marketin 10 March 2023
When new group chief executive Bill Anderson takes over at Bayer (BAYN: DE) in June, he will find a Pharmaceuticals Division that looks very different to the or 13 February 2023
An interview reflecting on 2022 and looking forward to the year ahead with Paul O'Donohoe senior director, eCOA Product and Science at Medidata. 26 January 2023
Never has the importance of Flanders’ biopharmaceutical output to the international community been more obvious than it was during the COVID-19 crisis. 3 January 2023
As with every sector, the biopharmaceutical field has its own lingo—a world of jargon and buzz words that develop alongside industry trends and wider societal c 11 November 2022
The questions that were posed to the biopharmaceutical industry in 2020 were more urgent than ever before, as the COVID-19 pandemic brought much of the world to 27 October 2022
Talking the talk alone is no longer enough for pharma companies where their digital strategies are concerned—now they need to walk the walk, too. 24 October 2022
In August, UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Sunlenca (lenacapavir) injection and tablets, alongside other antiretrovirals, in adu 21 October 2022
With the final presentations of this year’s meeting of the European Society of Medical Oncology (ESMO 22) in full swing, there is a lot for the scientific commu 12 September 2022
Yaneth Giha, the first woman to serve as executive director of FIFARMA, the Latin American Federation of the Pharmaceutical Industry, spoke to Angel Galindo, Th 1 September 2022
As President Joe Biden signs the Inflation Reduction Act into law.drugmakers in the USA are poring over the likely impact on drug prices.and how best to respond 17 August 2022
For years, commentators have observed that drug prices in the USA are significantly higher than elsewhere in the world. As the US Congress debates government ac 22 July 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.